Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for mitochondrial dysfunction is provided by mutations in genes that are associated with mitochondria in familial PD [e.g., mitochondrial kinase PINK (PTEN-induced kinase 1) and Parkin (Valente et al., 2004;Poole et al., 2008)], and features of PD are caused by mitochondrial toxins (Bove ´et al., 2005).”
From Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies (2008) · cites this paper as Valente et al., 2004
In the citing paper
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
From miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) (2016) · cites this paper as [10]
In the citing paper
“Multiple neurodegenerative diseases have dysfunctional mitophagic processes in neurons, as described in Parkinson’s disease (PD) (16), Huntington’s disease (17), amyotrophic lateral sclerosis (ALS) (18), and Alzheimer’s disease (AD) (19,20).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [16]
In the citing paper
“A causal association has been established between autosomal recessive forms of PD and mutations affecting the mitophagy regulators PINK1 (PTEN‐induced putative kinase 1) and PRKN/PARK2 (Parkin RBR E3 ubiquitin protein ligase) (Kitada et al, 1998; Valente et al, 2004; Narendra et al, 2008; Matsuda et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Valente et al, 2004
In the citing paper
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [211]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Self-citationChen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414
Research works printed but not linked: 1
- A. H. Schapiraet al., Lancet2, 1269 (1989).
Cited by
Items 701–800 of 1,043
Disruption of axonal transport in neurodegeneration
Berth, S. H., & Lloyd, T. E. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168554 · Cited by 149
Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish
Chen, Y., Priyadarshini, M., & Panula, P. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0619-8 · Cited by 136
Pankratz, N., & Foroud, T. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31815bf97c · Cited by 154
Genetic zebrafish models of neurodegenerative diseases
Bandmann, O., & Burton, E. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.017 · Cited by 150
Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
Gandhi, P. N., Chen, S. G., & Wilson‐Delfosse, A. L. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21949 · Cited by 123
Rakovic, A., Grunewald, A., Seibler, P., Ramirez, A., Kock, N., Orolicki, S., Lohmann, K., & Klein, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq215 · Cited by 124
Autophagy in Age-Associated Neurodegeneration
Metaxakis, A., Ploumi, C., & Tavernarakis, N. (2018) · Cells · doi:10.3390/cells7050037 · Cited by 117
Funayama, M., Li, Y., Tomiyama, H., Yoshino, H., Imamichi, Y., Yamamoto, M., Murata, M., Toda, T., Mizuno, Y., & Hattori, N. (2007) · NeuroReport · doi:10.1097/wnr.0b013e32801254b6 · Cited by 124
α-Synuclein and Mitochondria: Partners in Crime?
Nakamura, K. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0182-9 · Cited by 149
The role of glucocerebrosidase in Parkinson disease pathogenesis
Gegg, M. E., & Schapira, A. H. V. (2018) · The FEBS Journal · doi:10.1111/febs.14393 · Cited by 123
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Wong, Y. C., Luk, K., Purtell, K., Burke Nanni, S., Stoessl, A. J., Trudeau, L., Yue, Z., Krainc, D., Oertel, W., Obeso, J. A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27823 · Cited by 122
Jiang, G., Hu, Y., Liu, L., Cai, J., Peng, C., & Li, Q. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.06.003 · Cited by 122
Martin, L. J., Semenkow, S., Hanaford, A., & Wong, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.008 · Cited by 121
Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress
Shi, H., Deng, H.-X., Gius, D., Schumacker, P. T., Surmeier, D. J., & Ma, Y.-C. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx100 · Cited by 121
The integrated stress response in metabolic adaptation
Ryoo, H. D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107151 · Cited by 140
Abeliovich, H., Zarei, M., Rigbolt, K. T. G., Youle, R. J., & Dengjel, J. (2013) · Nature Communications · doi:10.1038/ncomms3789 · Cited by 114
Nagatsu, T., & Sawada, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9061-9 · Cited by 141
Mitophagy in neurodegeneration and aging
Palikaras, K., & Tavernarakis, N. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00297 · Cited by 121
Beyond the mitochondrion: cytosolic PINK 1 remodels dendrites through Protein Kinase A
Dagda, R. K., Pien, I., Wang, R., Zhu, J., Wang, K. Z. Q., Callio, J., Banerjee, T. D., Dagda, R. Y., & Chu, C. T. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12494 · Cited by 121
Wang, H., Chou, A.-H., Wu, A.-S., Chen, S.-Y., Weng, Y.-H., Kao, Y.-C., Yeh, T., Chu, P., & Lu, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.007 · Cited by 133
Mammalian mitophagy – from in vitro molecules to in vivo models
Rodger, C. E., McWilliams, T. G., & Ganley, I. G. (2018) · The FEBS Journal · doi:10.1111/febs.14336 · Cited by 121
Tsai, P.-I., Lin, C., Hsieh, C.-H., Papakyrikos, A. M., Kim, M. J., Napolioni, V., Schoor, C., Couthouis, J., Wu, R., Wszołek, Z. K., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.026 · Cited by 128
Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
Audano, M., Schneider, A., & Mitro, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14471 · Cited by 122
Mitochondrial Quality Control and Restraining Innate Immunity
Moehlman, A. T., & Youle, R. J. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-021820-101354 · Cited by 120
Zabetian, C. P., Hutter, C. M., Yearout, D., Lopez, A. N., Factor, S. A., Griffith, A., Leis, B. C., Bird, T. D., Nutt, J. G., Higgins, D. S., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508025 · Cited by 139
Animal models of Parkinson's disease: An updated overview
Gubellini, P., & Kachidian, P. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.07.011 · Cited by 146
Hypoxia Activation of Mitophagy and Its Role in Disease Pathogenesis
Wu, H., & Chen, Q. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6204 · Cited by 124
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease
Pacelli, C., Rasmo, D. D., Signorile, A., Grattagliano, I., Tullio, G. D., D’Orazio, A., Nico, B., Comi, G. P., Ronchi, D., Ferranini, E., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.022 · Cited by 133
Mitochondrial Biology and Neurological Diseases
Arun, S., Liu, L., & Donmez, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150703154541 · Cited by 119
Harnessing human ADAR2 for RNA repair – Recoding a PINK1 mutation rescues mitophagy
Wettengel, J., Reautschnig, P., Geisler, S., Kahle, P. J., & Stafforst, T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw911 · Cited by 120
Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1
Takatori, S., Ito, G., & Iwatsubo, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.019 · Cited by 119
Calcium signaling in Parkinson’s disease
Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 136
Parkin- and PINK1-Dependent Mitophagy in Neurons: Will the Real Pathway Please Stand Up?
Grenier, K., McLelland, G.-L., & Fon, E. A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00100 · Cited by 119
Autophagosome dynamics in neurodegeneration at a glance
Wong, Y. C., & Holzbaur, E. L. F. (2015) · Journal of Cell Science · doi:10.1242/jcs.161216 · Cited by 119
Park, J., Mehta, P., Cooper, A. A., Veivers, D., Heimbach, A., Stiller, B., Kubisch, C., Fung, V. S., Krainc, D., Mackay‐Sim, A., et al. (2011) · Human Mutation · doi:10.1002/humu.21527 · Cited by 118
Role of Epigenetics in Alzheimer ‘S and Parkinson‘S Disease
Kwok, J. B. (2010) · Epigenomics · doi:10.2217/epi.10.43 · Cited by 119
Lysosome‐dependent pathways as a unifying theme in Parkinson's disease
Tofaris, G. K. (2012) · Movement Disorders · doi:10.1002/mds.25136 · Cited by 118
van der Merwe, C., Dyk, H. C. V., Engelbrecht, L., van der Westhuizen, F. H., Kinnear, C. J., Loos, B., & Bardien, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9843-0 · Cited by 125
Protein Misfolding and Aggregation in Parkinson's Disease
Tan, J. M. M., Wong, E. S. P., & Lim, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2490 · Cited by 135
Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
Wang, D., Tang, B., Zhao, G., Pan, Q., Xia, K., Bodmer, R., & Zhang, Z. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-3 · Cited by 128
PINK1 Kinase Catalytic Activity Is Regulated by Phosphorylation on Serines 228 and 402
Aerts, L., Craessaerts, K., De Strooper, B., & Morais, V. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620906 · Cited by 118
Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles
Roberts, R. F., Tang, M. Y. H., Fon, E. A., & Durcan, T. M. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.020 · Cited by 127
Etiology and Pathogenesis of Parkinson Disease
Schapira, A. H. V. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.004 · Cited by 144
Simon-Sanchez, J., & Singleton, A. B. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn096 · Cited by 118
To die or grow: Parkinson's disease and cancer
WEST, A., DAWSON, V, & DAWSON, T. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.05.002 · Cited by 117
Moya-Alvarado, G., Gershoni-Emek, N., Perlson, E., & Bronfman, F. C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r115.053330 · Cited by 117
International Parkinson’s Disease Genetics Consortium (IPGDC), Jansen, I. E., Ye, H., Heetveld, S., Lechler, M. C., Michels, H., Seinstra, R. I., Lubbe, S. J., Drouet, V., Lesage, S., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1147-9 · Cited by 117
Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL
Koyano, F., Yamano, K., Kosako, H., Tanaka, K., & Matsuda, N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006302 · Cited by 116
Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes
Kubli, D. A., Quinsay, M. N., & Gustafsson, Å. B. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.24511 · Cited by 115
Pryde, K. R., Taanman, J., & Schapira, A. H. V. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.027 · Cited by 112
P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?
Szybińska, A., & Leśniakx, L. (2017) · Aging and disease · doi:10.14336/ad.2016.1120 · Cited by 116
Phosphorylation of Parkin at serine 65 is essential for its activation in vivo
McWilliams, T. G., Barini, E., Pohjolan-Pirhonen, R., Brooks, S. P., Singh, F., Burel, S., Balk, K., Kumar, A., Montava-Garriga, L., Prescott, A. R., et al. (2018) · Open Biology · doi:10.1098/rsob.180108 · Cited by 116
Self-citationBiomarkers of neurodegenerative disorders: How good are they?
Rachakonda, V., Pan, T. H., & Le, W. D. (2004) · Cell Research · doi:10.1038/sj.cr.7290235 · Cited by 134
Pathogenesis, diagnosis and treatment
Mark, M. H. (2005) · CRC Press eBooks · doi:10.1201/b14478-2 · Cited by 116
Radiation-induced autophagy: mechanisms and consequences
Chaurasia, M., Bhatt, A. N., Das, A., Dwarakanath, B. S. R., & Sharma, K. (2016) · Free Radical Research · doi:10.3109/10715762.2015.1129534 · Cited by 125
Ryter, S. W., Bhatia, D., & Choi, M. E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7518 · Cited by 114
Mitophagy: A novel perspective for insighting into cancer and cancer treatment
Song, C., Pan, S., Zhang, J., Li, N., & Geng, Q. (2022) · Cell Proliferation · doi:10.1111/cpr.13327 · Cited by 127
Mechanisms for Countering Oxidative Stress and Damage in Retinal Pigment Epithelium
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00004-3 · Cited by 115
Shen, J., & Cookson, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.012 · Cited by 123
PINK1 autophosphorylation is required for ubiquitin recognition
Rasool, S., Soya, N., Truong, L., Croteau, N., Lukács, G. L., & Trempe, J. (2018) · EMBO Reports · doi:10.15252/embr.201744981 · Cited by 122
Gustavsson, E. K., Follett, J., Trinh, J., Barodia, S. K., Real, R., Liu, Z., Grant-Peters, M., Fox, J. D., Appel-Cresswell, S., Stoessl, A. J., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00121-2 · Cited by 114
Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review
Kulkarni, A. D., Vanjari, Y. H., Sancheti, K. H., Belgamwar, V. S., Surana, S. J., & Pardeshi, C. V. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1020809 · Cited by 126
Xi, Y., Ryan, J., Noble, S., Yu, M., Yilbas, A. E., & Ekker, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07091.x · Cited by 128
A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease
Cook, C., & Petrucelli, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.012 · Cited by 113
Identifying regulatory elements in eukaryotic genomes
Narlikar, L., & Ovcharenko, I. (2009) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp014 · Cited by 141
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
Kanwar, J., Sriramoju, & Kanwar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30919 · Cited by 108
Setsuie, R., Wang, Y.-L., Mochizuki, H., Osaka, H., Hayakawa, H., Ichihara, N., Li, H., Furuta, A., Sano, Y., Sun, Y., et al. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.07.015 · Cited by 127
Oxidative Stress, Mitochondrial Dysfunction and the Mitochondria Theory of Aging
Kong, Y., Trabucco, S. E., & Zhang, H. (2014) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000358901 · Cited by 112
Dardiotis, E., Xiromerisiou, G., Hadjichristodoulou, C. S., Tsatsakis, A. M., Wilks, M. F., & Hadjigeorgiou, G. M. (2013) · Toxicology · doi:10.1016/j.tox.2012.12.016 · Cited by 114
Meissner, C., Lorenz, H., Hehn, B., & Lemberg, M. K. (2015) · Autophagy · doi:10.1080/15548627.2015.1063763 · Cited by 109
Synapses in neurodegenerative diseases
Bae, J. R., & Kim, S. H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.5.038 · Cited by 111
Genetics of neurodegenerative diseases: an overview
Pihlstrøm, L., Wiethoff, S., & Houlden, H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00022-5 · Cited by 130
Huang, E., Qu, D., Huang, T., Rizzi, N., Boonying, W., Krolak, D., Ciana, P., Woulfe, J., Klein, C., Slack, R. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01435-1 · Cited by 111
USP 14 inhibition corrects an in vivo model of impaired mitophagy
Chakraborty, J., von Stockum, S., Marchesan, E., Caicci, F., Ferrari, V., Rakovic, A., Klein, C., Antonini, A., Bubacco, L., & Ziviani, E. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809014 · Cited by 110
Roca-Agujetas, V., Barbero-Camps, E., de Dios, C., Podlesniy, P., Abadin, X., Morales, A., Marí, M., Trullàs, R., & Colell, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00435-6 · Cited by 111
Kinases and kinase signaling pathways: Potential therapeutic targets in Parkinson's disease
Wang, G., Pan, J., & Chen, S. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.003 · Cited by 124
PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1
Requejo-Aguilar, R., López-Fabuel, I., Fernández, E., Martins, L. M., Almeida, Á., & Bolaños, J. P. (2014) · Nature Communications · doi:10.1038/ncomms5514 · Cited by 115
Parkinson’s disease: experimental models and reality
Jiang, P., & Dickson, D. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1788-5 · Cited by 111
Disease model organism for Parkinson disease: Drosophila melanogaster
Aryal, B., & Lee, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.4.204 · Cited by 111
Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond
Bayne, A. N., & Trempe, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03203-4 · Cited by 130
Costa, C. A. D., Manaa, W. E., Duplan, E., & Checler, F. (2020) · Cells · doi:10.3390/cells9112495 · Cited by 110
Genetics of Parkinson's disease.
Gasser, T. (2004) · Europe PMC (PubMed Central) · Cited by 111
A short linear motif in BNIP3L (NIX) mediates mitochondrial clearance in reticulocytes
Zhang, J., Loyd, M. R., Randall, M. S., Waddell, M. B., Kriwacki, R. W., & Ney, P. A. (2012) · Autophagy · doi:10.4161/auto.20764 · Cited by 111
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
Scheele, C., Nielsen, A. R., Walden, T. B., Sewell, D. A., Fischer, C. P., Brogan, R. J., Petrovic, N., Larsson, O., Tesch, P. A., Wennmalm, K., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8520com · Cited by 110
Grünewald, A., Gegg, M. E., Taanman, J.-W., King, R. H., Kock, N., Klein, C., & Schapira, A. H. V. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.027 · Cited by 102
Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms
Bose, A., Petsko, G. A., & Eliezer, D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171263 · Cited by 118
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
Niemann, N., & Jankovic, J. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.025 · Cited by 135
Genetics of Parkinson's disease
Cherian, A., & Divya, K. P. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01473-5 · Cited by 131
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Arena, G., Sharma, K., Agyeah, G., Krüger, R., Grünewald, A., & Fitzgerald, J. C. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01207-5 · Cited by 128
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire‐Zeiss, K. A., Short, D. W., & Federoff, H. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.014 · Cited by 127
The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation
Xu, X. M., Lin, H., Maple‐Grødem, J., Björkblom, B., Alves, G. W., Larsen, J. P., & Møller, S. G. (2010) · Journal of Cell Science · doi:10.1242/jcs.063222 · Cited by 127
TRAP1 rescues PINK1 loss-of-function phenotypes
Zhang, L., Karsten, P., Hamm, S., Pogson, J. H., Müller-Rischart, A. K., Exner, N., Haass, C., Whitworth, A. J., Winklhofer, K. F., Schulz, J. B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt132 · Cited by 108
Mitochondrial fission and fusion in secondary brain damage after CNS insults
Balog, J., Mehta, S. L., & Vemuganti, R. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16671528 · Cited by 108
Kumar, A., Chaugule, V. K., Condos, T. E. C., Barber, K. R., Johnson, C., Toth, R., Sundaramoorthy, R., Knebel, A., Shaw, G. S., & Walden, H. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3400 · Cited by 109
Mitophagy and the release of inflammatory cytokines
Harris, J., Deen, N. S., Zamani, S., & Hasnat, M. A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.10.009 · Cited by 113
Gao, Q., Tian, R., Han, H., Slone, J. D., Wang, C., Ke, X., Zhang, T., Li, X., He, Y., Liao, P., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00933-z · Cited by 122
Impact of recent genetic findings in Parkinson??s disease
Klein, C., & Lohmann-Hedrich, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281e6692b · Cited by 135
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries
Tomiyama, H., Li, Y., Funayama, M., Hasegawa, K., Yoshino, H., Kubo, S., Sato, K., Hattori, T., Lu, C., Inzelberg, R., et al. (2006) · Movement Disorders · doi:10.1002/mds.20886 · Cited by 120
PINK1 (PARK6) associated Parkinson disease in Ireland
Healy, D. G., Abou‐Sleiman, P. M., Gibson, J. M., Ross, O. A., Jain, S., Gandhi, S., Gosal, D. Y., Muqit, M. M. K., Wood, N. W., & Lynch, T. (2004) · Neurology · doi:10.1212/01.wnl.0000142089.38301.8e · Cited by 109
Self-citationPathogenic Mechanisms of Neurodegeneration in Parkinson Disease
Mullin, S., & Schapira, A. H. V. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.010 · Cited by 108
Metadata
- Authors
- Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., & Wood, N. W.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- CSS IRCCS, Mendel Institute, viale Regina Margherita 261, 00198 Rome, Italy.
- Goethe University Frankfurt (DE)
- Università Cattolica del Sacro Cuore (IT)
- National Institutes of Health (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Valente, Enza Maria
- ORCID
- Venue
- Science
- Published
- 2004-05-21
- Volume
- 304
- Issue
- 5674
- Pages
- 1158-1160
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2136388422
- Cited by
- 3,481
- References
- 19
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 133 · 2022: 158 · 2021: 187 · 2020: 182 · 2019: 158 · 2018: 167 · 2017: 189 · 2016: 147 · 2015: 151 · 2014: 158 · 2013: 177 · 2012: 163
- FWCI
- 109.31
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Parkinson's UK (G-4029)
- Brain Research Trust
- Deutsche Forschungsgemeinschaft
- Ministero della Salute
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, PINK1, mitochondrial dysfunction, dopaminergic neuron loss, consanguineous family, nonsense mutation, missense mutations, mitochondrial localization
- MeSH terms
- PTEN-Induced Putative Kinase, Amino Acid Sequence, Animals, Exons, Humans, Leupeptins, Membrane Potentials, Mitochondria, Molecular Sequence Data, Mutation, Neurons, Parkinson Disease, Protein Kinases, Transfection, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Codon, Nonsense, COS Cells, Mutation, Missense, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.